Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-08-012743
Filing Date
2008-05-15
Accepted
2008-05-15 17:26:41
Documents
1
Period of Report
2008-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3883
  Complete submission text file 0001140361-08-012743.txt   5776
Mailing Address 420 LEXINGTON AVE SUITE 408 NEW YORK NY 10170
Business Address 420 LEXINGTON AVE SUITE 408 NEW YORK NY 10170 2126729100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 EAST 62ND STREET NEW YORK NY 10021
Business Address 212-572-5150
Fasman Steven L (Reporting) CIK: 0001397844 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23047 | Film No.: 08839527